Advertisement

Urinary System pp 248-255 | Cite as

Suppurative Nephritis and Pyelonephritis, Rat

  • Pierre Duprat
  • Joe D. Burek
Part of the Monographs on Pathology of Laboratory Animals book series (LABORATORY)

Abstract

In the early stage, no changes are seen grossly. Advanced stages can be characterized by an increased size and discoloration of the kidneys. In suppurative nephritis, changes are mostly confined to the cortex. The inflammation produces numerous small, yellow nodules, well delineated and surrounded by a red rim and usually more frequent in the cortex than in the medulla.

Keywords

Synonyms 1. Suppurative (or purulent) nephritis hematogenous nephritis metastatic or embolic nephritis excretion nephritis pyonephritis. 2. Pyelonephritis ascending or urogenous (pyelo-)nephritis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Appleton JA, De Buysscher EV, Kadis S (1979) Antibody formation in Corynebacterium rena Ie-induced experimental pyelonephritis in the rat. Am J Vet Res 40:1757- 1761PubMedGoogle Scholar
  2. Appleton JA, Munnell JF, De Buysscher EV (1981) Scanning electron microscopy of experimentally induced pyelonephritis in the rat. Am J Vet Res 42:351–355PubMedGoogle Scholar
  3. Auclair P, Lessard C, Bergeron MG (1988) Renal pharmacokinetic changes of gentamicin during enterococcal pyelonephritis. Antimicrob Agents Chemother 32:736–739PubMedGoogle Scholar
  4. Baumgart P, Muller KM, Lison AE (1983) Epithelial abnormalities in the renal pelvis in experimental hydronephrosis and pyelonephritis. Pathol Res Pract 176:185–195PubMedCrossRefGoogle Scholar
  5. Beauchamp D, Bouchard A, Theriault G, Pellerin M, Bergeron MG (1990) Effect of E. coli pyelonephritis on the intra cortical accumulation kinetics of gentamicin and netilmicin in rats. Clin Invest Med 13:145–151Google Scholar
  6. Bergeron MG, Marois Y, Kuehn C, Silverblatt FJ (1987) Autoradiographic study of tobramycin uptake by proximal and distal tubules of normal and pyelonephritic rats. Antimicrob Agents Chemother 31:1359–1364PubMedGoogle Scholar
  7. Bille J, Glauser MP (1982) Protection against chronic pyelonephritis in rats by suppression of acute suppuration: effect of colchicine and neutropenia. J Infect Dis 146:220–226PubMedCrossRefGoogle Scholar
  8. Camprubi S, Merino S, Benedi VJ, Tomas JM (1993) The role of the O-antigen lipopolysaccharide and capsule on an experimental Klebsiella pneumoniae infection of the rat urinary tract. FEMS Microbiol Lett 111:9–13PubMedCrossRefGoogle Scholar
  9. Casey HW, Ayers KM, Robinson FR (1978) The urinary system. In: Bernirschke K, Garner FM, Jones TC (eds) Pathology of laboratory animals, vol 1. Springer, New York Berlin Heidelberg, pp 115–173CrossRefGoogle Scholar
  10. Claesson G, Josephson S, Robertson B (1987) Renal recovery after release of experimental neonatal ureteric obstruction. Urol Int 42:353–359PubMedCrossRefGoogle Scholar
  11. Clark EC, Nath KA, Hostetter MK, Hostetter TH (1990) Role of ammonia in tubulointerstitial injury. Miner Electrolyte Metab 16:315–321PubMedGoogle Scholar
  12. Coe FL (1981) Clinical and laboratory assessment of the patient with renal disease. In: Brenner BM, Rector FC (eds) The kidney, vol 1. Saunders, Philadelphia, pp 1135–1180Google Scholar
  13. Coe FL. Farvus MV (1981) Disorders of stone formation. In: Brenner BM, Rector FC (eds) The kidney, vol. 2. Saunders, Philadelphia, pp 1950–2007Google Scholar
  14. Corriere IN Jr, Murphy JJ (1967) Vesico ureteral reflux and the intrarenal lymphatic system in the rat. Invest Urol 4:556–569PubMedGoogle Scholar
  15. Cotran RS (1969) Experimental pyelonephritis. In: Rouiller C, Muller AF (eds) The kidney. vol 2. Academic, New York, pp 269–261Google Scholar
  16. Cotran RS, Pennington JE (1981) Urinary tract infection, pyelonephritis and reflux nephropathy. In: Brenner BM, Rector FC (eds) The kidney, vol 2. Saunders, Philadelphia, pp 1571–1629Google Scholar
  17. Crowell WA, Finco DR (1975) Frequency of pyelitis, pyelonephritis, renal perivasculitis and renal infarction in dogs. Am J Vet Res 36:111–114PubMedGoogle Scholar
  18. Dublin M, Shimamura T (1975) An ultrastructural study of the renal medulla in experimental acute pyelonephritis. Yale J Bioi Med 48:211–216Google Scholar
  19. Fussell EN, Roberts JA (1984) The ultrastructure of acute pyelonephritis in the monkey. J Urol 132:179–183PubMedGoogle Scholar
  20. Garg UC, Ganguly NK, Bhatnagar R (1987) Towards the mechanism of altered nutrients uptake in renal brush border membrane vesicles from pyelonephritic rats. Biochem Int 14:949–956PubMedGoogle Scholar
  21. Gargallo D, Moros M, Coli R, Esteve M, Pares J, Xicota MA, Guinea J (1988) Activity of E-3846 a new fluoroquinolone in vitro and in experimental cystitis and pyelonephritis in rats. Antimicrob Agents Chemother 32:636–641PubMedGoogle Scholar
  22. Goto T, Kawahara M, Kawahara K, Mahinose S, Mizuma Y, Sakamoto N, Ohi Y (1991) Experimental bacterial prostatitis in rats. Urol Res 19:141–144PubMedCrossRefGoogle Scholar
  23. Guignard JP (1983) Importance of vesico-ureteral reflux in the pathogenesis of chronic pyelonephritis (in German). Schweiz Med Wochenschr 113:223–228PubMedGoogle Scholar
  24. Hannerz L, Celsi G, Eklof AC, Oiling S, Wikstad I, Aperia A (1989) Ascending pyelonephritis in young rats retards kidney growth. Kidney Int 35:1133–1137PubMedCrossRefGoogle Scholar
  25. Haraoka M, Matsumoto T, Mizunoe Y, Ogata N, Takahashi K, Kubo S, Tanaka M (1993) Effect of prednisolone on renal scarring in rats following infection with Sarratia marcescens. Ren Fail 15:567–571PubMedCrossRefGoogle Scholar
  26. Haraoka M, Matsumoto T, Takahashi K, Kubo S, Tanaka M, Kumazawa J (1994) Suppression of renal scarring by prednisolone combined with ciprofloxacin in ascending pyelonephritis in rats. J UroI 151:1078–1080Google Scholar
  27. Hard GC, Neal GE (1992) Sequential study of the chronic nephrotoxicity induced by dietary administration of ethoxyquin in Fischer 344 rats. Fundam Appl Toxicol 18:278–287PubMedCrossRefGoogle Scholar
  28. Heptinstall RH (1984) Infections, reflux and pyelonephritis. 4th ILSI Histopathology Seminar on the Urinary System of Laboratory Animals, session B, Hannover, 26–28 Sept 1984Google Scholar
  29. Hutch JA (1952) Vesico ureteral reflux in the paraplegic: cause and correction. J Urol 68:457–467PubMedGoogle Scholar
  30. Hutch JA, Amor AD (1972) Vesico ureteral reflux and pyelonephritis. Meredith, New YorkGoogle Scholar
  31. Ivanyi B (1991) Hypoxic damage to tubules due to blockage of perfusion in acute hematogenous E. coli pyelonephritis of rats. Acta Morphol Hung 39:238–248Google Scholar
  32. Ivanyi B, Ormos J, Lantos J (1983) Tubulointerstitial inflammation, cast formation, and renal parenchymal damage in experimental pyelonephritis. Am J Pathol 113:300–308PubMedGoogle Scholar
  33. Ivanyi B, Krenacs T, Dobo E, Ormos J (1990) Demonstration of bacterial antigen in macrophages in experimental pyelonephritis. Virchows Arch B Cell Pathol 59:83–88CrossRefGoogle Scholar
  34. Janson KL, Roberts JA (1978) Experimental pyelonephritis. V. Functional characteristics of pyelonephritis. Invest Urol 15:397–400PubMedGoogle Scholar
  35. Johannsson H, Grimelius L, Andersson A, Ejerblad S (1974) Secondary hyperparathyroidism in rats with experimentally induced pyelonephritis. Urol Res 2:11–20PubMedCrossRefGoogle Scholar
  36. Johnston WH, Latta H (1978) Acute hematogenous pyelonephritis in the rabbit. Electron microscopic study of Escherichia coli localization and early acute inflammation. Lab Invest 38:439–446PubMedGoogle Scholar
  37. Jones TC, Hunt RD (1983) Veterinary pathology, 5th edn. Lea and Febiger, PhiladelphiaGoogle Scholar
  38. Jubb KVF, Kennedy PC (1985) Pathology of domestic animals, vol 2. Academic, New York, pp 379–385Google Scholar
  39. Kaijser B, Larsson P (1982) Experimental acute pyelonephritis caused by enterobacteria in animals. A review. J Uro1 127: 786–790Google Scholar
  40. Kruze D, Biro K, Holzbecher K, Andrial M, Bossart W (1992) Protection by a polyvalent vaccine against challenge infection and pyelonephritis. Urol Res 20:177–181PubMedCrossRefGoogle Scholar
  41. Kurnick JT, McCluskey RT, Bhan AK, Wright KA, Wilkinson R, Rubin RH (1988) Escherichia coli-specific T lymphocytes in experimental pyelonephritis. J ImmunoI 141:3220–3226Google Scholar
  42. Larsson P, Kaijser B, Baltzer 1M, Oiling S (1980) An experimental model for ascending acute pyelonephritis caused by Escherichia coli or proteus in rats. J Clin PathoI 33:408–412CrossRefGoogle Scholar
  43. Mackenzie R, Asscher A W (1986) Progression of chronic pyelonephritis in the rat. Nephron 42:171–176PubMedCrossRefGoogle Scholar
  44. Matsumoto T, Mizunoe Y, Sakamoto N, Kumazawa J (1990) Suitability of colchicine and superoxide dismutase for the suppression ofrenal scarring following an infection with bacteria showing mannose-sensitive pili. Nephron 56:130–135PubMedCrossRefGoogle Scholar
  45. Matsumoto T, Haraoka M, Mizunoe Y, Kubo S, Takahashi K, Tanaka M, Kumazawa J (1993) Renal scarring is enhanced by phorbol myristate acetate following infection with bacteria with mannose-sensitive pili. Nephron 64:405–409PubMedCrossRefGoogle Scholar
  46. Mayrer AR, Miniter P, Andriole VT (1983) Immunopathogenesis of chronic pyelonephritis. Am J Med 75 (lB):59–70PubMedCrossRefGoogle Scholar
  47. McCluskey RT, Bhan AK (1982) Cell-mediated mechanisms in renal diseases. Kidney Int [Suppl] 11:6–12Google Scholar
  48. Meylan PR, Glauser MP (1988) Failure of dexamethasone to prevent polymorphonuclear leukocyte infiltration during experimental acute exudative pyelonephritis and to reduce subsequent chronic scarring. J Infect Dis 157:480–485PubMedCrossRefGoogle Scholar
  49. Meylan PR, Markert M, Bille J, Glauser MP (1989) Relationship between neutrophil-mediated oxidative injury during acute experimental pyelonephritis and chronic renal scarring. Infect Immun 57:2196–2202PubMedGoogle Scholar
  50. Miller TE, Findon G (1988) Exacerbation of experimental pyelonephritis by cyclosporin A. J Med Microbiol 26:245–250PubMedCrossRefGoogle Scholar
  51. Miller T, Marshall E (1980) Suppressor cell regulation of cell-mediated immune responses in renal infection: in vitro modulation of suppressor cell activity. J Clin Invest 66:621–628PubMedCrossRefGoogle Scholar
  52. Miller T, Phillips S (1981) Pyelonephritis: the relationship between infection, renal scarring, and antimicrobial therapy. Kidney Int 19:654–662PubMedCrossRefGoogle Scholar
  53. Miller TE, Layzell D, Stewart E (1976) Experimental pyelonephritis: the effect of chronic active pyelonephritis on renal function. Kidney Int 9:23–29PubMedCrossRefGoogle Scholar
  54. Miller TE, Findon G, Ormrod DJ (1992a) Suppression of inflammation by cyclosporin A is mediated via a T lymphocyte-independent process. Pharm Res 9:1252–1255PubMedCrossRefGoogle Scholar
  55. Miller TE, Findon G, Rainer SP, Gavin JB (1992b) The pathobiology of subclinical pyelonephritis - an experimental evaluation. Kidney Int 41:1356–1365PubMedCrossRefGoogle Scholar
  56. Nagai T (1984) Morphologic and immunohistologic study of pyelonephritis in rats by various bacteria and fungi. Special reference to inflammatory changes and localization of antigen. Nephron 37:264–269PubMedCrossRefGoogle Scholar
  57. Nieberle K, Cohrs P (1967) Textbook of the special pathological anatomy of domestic animals. Pergamon, Oxford, pp 694–699Google Scholar
  58. Okamura T, Garland EM, Taylor RJ, Johansson SL, Cohen SM (1992) The effect of cyclophosphamide administration on the kidney of the rat. Toxicol Lett 63:261–276PubMedCrossRefGoogle Scholar
  59. Pickering WJ, Birch DF (1989) Bacteriologic and serologic findings in experimental pyelonephritis caused by Ureaplasma-urealyticum. Infect Immun 57:1235–1239PubMedGoogle Scholar
  60. Ransley PG, Risdon RA (1978) Reflux and renal scarring. Br J Radiol 51 [SuppI14]:1–35Google Scholar
  61. Roberts JA (1983) Vesico ureteral reflux in the monkey: a review. Urol Radiol 5:211–217, 219PubMedCrossRefGoogle Scholar
  62. Roberts JA, Ricker P (1978) Experimental pyelonephritis in the monkey. VI. Infection of infants versus adults. Invest UroI 16:128–130Google Scholar
  63. Santos WLC, Andrade ZA, Rocha H (1994) Dynamics of connective matrix deposition in acute experimental E. coli pyelonephritis in rats. Exp Toxicol Pathol 46:63–69CrossRefGoogle Scholar
  64. Shimamura T (1981) Mechanisms of renal tissue destruction in an experimental acute pyelonephritis. Exp Mol Pathol 34:34–42PubMedCrossRefGoogle Scholar
  65. Smith TW Jr, Roberts JA (1978a) Chronic pyelonephritis. An electron microscopic study in nonhuman primates. Invest Urol 16:148–153PubMedGoogle Scholar
  66. Smith TW Jr, Roberts JA (1978b) Chronic pyelonephritis. Electron microscopic study. II. Persistence of variant bacterial forms. Invest Urol 16:154–162PubMedGoogle Scholar
  67. Sorger K, Philippson C, Christ J (1977) Semi quantitative histological examination of the kidneys of rabbits (64- day, lOO-day and 212-day series) with experimentally induced pyelonephritis. Exp PathoI14:33–39Google Scholar
  68. Tardif M, Beauchamp D, Bergeron Y, Lessard C, Gourde P, Bergeron MG (1994) L-651,392, a potent leukotriene inhibitor, controls inflammatory process in Escherichia coli pyelonephritis. Antimicrob Agents Chemother 38:1555–1560PubMedGoogle Scholar
  69. Tomizawa S, Kjellson B, Fasth A, Hagberg M, Jodal U, Kaijser B, Soderstrom T, Hanson LA (1988) Antibodydependent cell-mediated cytotoxicity against Tamm Horsfall protein in acute pyelonephritis. Int Arch Allergy Appl Immunol 85:302–307PubMedCrossRefGoogle Scholar
  70. Tsuchida S, Yamaguchi 0, Arai S, Fukuchi S (1976) Hypertension and plasma renin activity in experimentally induced chronic pyelonephritis. Nephron 17:215- 223PubMedCrossRefGoogle Scholar
  71. van Aswegen CH, du Toit PJ, Nel JD, Ligthelm AJ, du Plessis DJ (1994) Pyelonephritis: renal urokinase and sialidase (neuraminidase) activity in rats fed a standard laboratory diet. Urol Res 22:57–60PubMedCrossRefGoogle Scholar
  72. Wilz SW, Kurnick JT, Pandolfi F, Rubin RH, Warren HS, Goldstein R, Kersten CM, McCluskey RT (1993) T lymphocyte responses to antigens of gram-negative bacteria in pyelonephritis. Clin Immunol Immunopathol 69:36–42PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • Pierre Duprat
  • Joe D. Burek

There are no affiliations available

Personalised recommendations